Experts in biotech and pharmaceutical pricing and market access
MEET THE TEAM
Working with you,
and for you
At RJW&partners our team are fully experienced in working with government, regulatory authorities and healthcare systems across the world.
RJW&partners is always interested in hearing from great people who are looking for a new challenge.
Neil Johnson
EXECUTIVE DIRECTOR
Over thirty years’ pricing and market access experience including at Cambridge Pharma Consultancy (now IQVIA) and as global head, pricing and market access at AstraZeneca.
Co-founded RJW & partners in 2008.
Nicola Robb
DIRECTOR
Extensive experience planning and leading global pricing and market access strategy projects; skilled delivery of advisory boards and negotiation workshops across therapy areas.
MA (Cantab) in Law and Social Anthropology.
Catherine Beecher
DIRECTOR
Twenty years’ pricing and market access consulting experience in US and EU at Cambridge Pharma Consultancy (now IQVIA) and PriceSpective/ICON.
Previously led UK pricing and market access at Bristol-Myers Squibb.
Åsa Kornfeld
DIRECTOR
Twenty years’ pricing and market access experience including at Parexel, Creativ-ceutical and Lundbeck. Three years’ clinical research.
BSc in Chemistry; MSc in Medicines and Healthcare Products. Swedish (native) and French speaker.
Claire Bark
ASSOCIATE DIRECTOR
Worked at Cambridge Pharma (now IQVIA), Wood Mackenzie and Complete Market Access. Specialist in pricing and market access strategy, value proposition development and communication.
BSc in Biomedical Science.
Ad Rietveld
SENIOR ADVISER
Over thirty years’ pricing and market access experience. Former Dutch national payer; industry marketing experience at Solvay. Consultant to World Bank, EU Commission and WHO. Physician; bilingual Dutch/English.
Co-founded RJW & partners in 2008.
Chloë Brown
SENIOR ADVISER
Twenty years’ pricing and market access experience including at Cambridge Pharma Consultancy (now IQVIA) and Mapi Values France. Over a decade in industry clinical research (US, Europe).
PhD in pharmacology; Diploma in Health Economics. French speaker.
